Lymph node micrometastases in non-small-cell lung cancer: Clinical applications

Clinical Lung Cancer

Volumn 2, Issue 2, 2000, Pages 116-120

  Perez Cardona, Jorge H ^a   Ordonez, Nelson G ^a   Fossella, Nelson G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytokeratin; Immunohistochemistry; Lung cancer; Lymph nodes; Micrometastases

Indexed keywords

CELL SURFACE PROTEIN; CYTOKERATIN; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; COST; EARLY CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0034463946     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2000.n.023     Document Type: Review

References (52)

1. Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?
2. Adjuvant therapy for stage I and II non-small cell lung cancer
3. Non-small cell lung cancer
4. Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer
5. -7
6. Review: Polymerase chain reaction detection of micrometastases and circulating tumor cells: Application to melanoma, prostate, and thyroid carcinomas
7. Recent advances in bone marrow scanning
8. Biological characteristics of micrometastatic cancer cells in bone marrow
9. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases
10. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival
11. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies
12. Micrometastatic bone marrow involvement: Detection and prognostic significance
13. Detection of occult metastases in lung carcinomas: Progress and implications for lung cancer staging
14. Prognostic significance of micrometastatic bone marrow involvement
15. Minimal residual disease in breast cancer
16. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction
17. Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer
18. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction
19. Micrometastasis in colorectal carcinoma: A review
20. The significance of intraoperative periportal lymph node metastasis identification in patients with colorectal carcinoma
21. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin
22. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
23. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma
24. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas?
25. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer
26. Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis
27. Keratin immunohistochemistry: Update of applications and pitfalls
28. Cytokeratins in normal lung and lung carcinomas. Adenocarcinomas, squamous cell carcinomas and cultured cell lines
29. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies
30. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas
31. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues
32. Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelial
33. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: Significance of nodal micrometastasis
34. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer
35. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance
36. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
37. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
38. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification
39. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
40. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
41. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen and cytokeratin 20
42. Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?
43. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma
44. Developmental expression of mucin genes MUC1 and MUC2
45. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization
46. Heterogeneity of mucin gene expression in normal and neoplastic tissues
47. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction
48. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn
49. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization
50. Peripheral airway cell differentiation in human lung cancer cell lines
51. Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features
52. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: Detection by reverse transcriptase-polymerase chain reaction